1 results match your criteria: "Case Western University and MetroHealth Medical Center[Affiliation]"
Am J Obstet Gynecol
February 1998
Department of Reproductive Biology and Obstetrics and Gynecology, Case Western University and MetroHealth Medical Center, Cleveland, Ohio 44106, USA.
Objective: Our purpose was to assess the effects of an intravenous dose of a highly selective mu-(DALDA) and delta-(DPDPE) opioid peptide to determine which class of peptide has the best clinical potential.
Study Design: Chronically instrumented pregnant ewes received a 0.3 mg/kg intravenous bolus of each peptide with and without opioid receptor blockade by means of a randomized prospective design.